Evidence map›Paper›PMID 34674672›Full record

ArticleBMC public health2021

Spatial analysis of colorectal cancer outcomes and socioeconomic factors in Virginia.

Esther J Thatcher, Fabian Camacho, Roger T Anderson, Li Li, Wendy F Cohn, Pamela B DeGuzman, Kathleen J Porter, Jamie M Zoellner

Open access · goldAbstract read
In one paragraph

Article in BMC public health, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
1.7field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 22 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. A Practical Strategy of Informatics, Geospatial Mapping, Geodemographic Segmentation, and Regression Analyses to Address Nonadherence to Colorectal Cancer Screening.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2026
    Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Area-level Socioeconomic Disadvantage and Cancer Survival in Metropolitan Detroit.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Esther J ThatcherUniversity Hospitals, Cleveland, OH, USA. esther.thatcher@uhhospitals.org.ORCID 0000-0002-3195-2894
Fabian CamachoDepartment of Public Health Sciences, School of Medicine, University of Virginia, Charlottesville, USA.
Roger T AndersonDepartment of Public Health Sciences, School of Medicine, University of Virginia, Charlottesville, USA.
Li LiDepartment of Family Medicine, School of Medicine, University of Virginia, Charlottesville, USA.
Wendy F CohnDepartment of Public Health Sciences, School of Medicine, University of Virginia, Charlottesville, USA.
Pamela B DeGuzmanSchool of Nursing, University of Virginia, Charlottesville, USA.
Kathleen J PorterDepartment of Public Health Sciences, School of Medicine, University of Virginia, Charlottesville, USA.
Jamie M ZoellnerDepartment of Public Health Sciences, School of Medicine, University of Virginia, Charlottesville, USA.
University of Virginia · USUniversity Hospitals of Cleveland · US

Funding

Role of MYC-MIZ1 signaling and the inflammatory immune microenvironment in Triple-Negative Breast Cancer Racial DisparitiesP20CA233216 · NCI · CASE WESTERN RESERVE UNIVERSITY · PI LI, LI · 2018 to 2021
$3.6M
NCI NIH HHS P20 CA233216
6 · The paper itself

Abstract

backgroundColorectal cancer (CRC) disparities vary by country and population group, but often have spatial features. This study of the United States state of Virginia assessed CRC outcomes, and identified demographic, socioeconomic and healthcare access contributors to CRC disparities.

methodsCounty- and city-level cross-sectional data for 2011-2015 CRC incidence, mortality, and mortality-incidence ratio (MIR) were analyzed for geographically determined clusters (hotspots and cold spots) and their correlates. Spatial regression examined predictors including proportion of African American (AA) residents, rural-urban status, socioeconomic (SES) index, CRC screening rate, and densities of primary care providers (PCP) and gastroenterologists. Stationarity, which assesses spatial equality, was examined with geographically weighted regression.

resultsFor incidence, one CRC hotspot and two cold spots were identified, including one large hotspot for MIR in southwest Virginia. In the spatial distribution of mortality, no clusters were found. Rurality and AA population were most associated with incidence. SES index, rurality, and PCP density were associated with spatial distribution of mortality. SES index and rurality were associated with MIR. Local coefficients indicated stronger associations of predictor variables in the southwestern region.

conclusionsRurality, low SES, and racial distribution were important predictors of CRC incidence, mortality, and MIR. Regions with concentrations of one or more factors of disparities face additional hurdles to improving CRC outcomes. A large cluster of high MIR in southwest Virginia region requires further investigation to improve early cancer detection and support survivorship. Spatial analysis can identify high-disparity populations and be used to inform targeted cancer control programming.

Indexed as

Colorectal NeoplasmsCross-Sectional StudiesHumansSocioeconomic FactorsSpatial AnalysisUnited StatesVirginiaColorectal neoplasmsIncidenceRisk factorsSpatial regressionVirginia

Identifiers

PMID34674672
PMCPMC8529747
OpenAlexW3206777281

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.